A Rockville-based pharmaceutical company is expecting to speed up development of an eye drop after its joint venture partner secured $7.28 million in South Korean investments. RegeneRx Biopharmaceuticals Inc. announced Monday that its partner and licensee, G-treeBNT Co. Ltd., will ...Read More »
RegeneRx Biopharmaceuticals Inc., of Rockville, has agreed to a joint venture agreement with South Korean pharmaceutical company G-treeBNT Co. Ltd. to develop RGN-259 for dry eye syndrome and neurotrophic keratitis in the United States. RegeneRx will receive $1 million and ...
Tagged with: RegeneRx BiopharmaceuticalsRead More »
The U.S. Patent and Trademark Office has extended three patents held by RegeneRx Biopharmaceuticals Inc., of Rockville, the company announced. The extensions were based on new rules contained in the America Invents Act Technical Corrections Act. A patent for a ...Read More »